Supernus Pharmaceuticals, Inc. (SUPN) Financials

SUPN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.4 billion 396.9 million
March 31, 2026 1.5 billion 423.9 million
Dec. 31, 2025 1.5 billion 390.9 million
Sept. 30, 2025 1.4 billion 370.1 million

SUPN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.4 million 8.6 million
March 31, 2026 66.5 million 8.5 million
Dec. 31, 2025 19.4 million 33.1 million
Sept. 30, 2025 -61.8 million 7.8 million

SUPN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -58.4 million
March 31, 2026 -2.3 million
Dec. 31, 2025 -38.6 million
Sept. 30, 2025 -45.1 million

SUPN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 372.1 million - 29.4 million
March 31, 2026 384.2 million - 30.3 million
Dec. 31, 2025 308.7 million - 41.0 million
Sept. 30, 2025 281.2 million - 42.2 million

SUPN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 58.1 million
March 31, 2026 57.6 million
Dec. 31, 2025 57.3 million
Sept. 30, 2025 56.6 million

SUPN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 568000 29.5 million 133.6 million 92.8 million
March 31, 2026 - 39.4 million 125.2 million -
Dec. 31, 2025 427000 27.8 million 122.4 million 83.2 million
Sept. 30, 2025 129000 29.4 million 179.7 million 77.1 million

SUPN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 219.1 million 33.7 million
March 31, 2026 207.7 million 23.4 million
Dec. 31, 2025 211.6 million 23.0 million
Sept. 30, 2025 192.1 million 19.0 million

SUPN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SUPN

Price: $39.57

52 week price:
39.57
59.68

Earnings Per Share: -1.90 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 524852

Ebitda: 27.4 million

Market Capitalization: 2.5 billion

Links: